Autologous Neoantigen-Specific T-Cell Therapy for Advanced Hepatocellular Carcinoma

NCT07123545 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Advanced Hepatocellular Carcinoma (HCC)

Interventions

BIOLOGICAL: iNeo-Vac-P01 Personalized Neoantigen Peptide Vaccine
BIOLOGICAL: iNeo-Vac-T01 Personalized T Cell Injection

Sponsor

Zhejiang University

Collaborators

[object Object]